CSat Investment Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$3K Hold
7
﹤0.01% 511
2020
Q4
$3K Sell
7
-2,174
-100% -$1.02M ﹤0.01% 508
2020
Q3
$963K Buy
2,181
+188
+9% +$77.7K 0.09% 107
2020
Q2
$723K Buy
1,993
+138
+7% +$46.3K 0.09% 123
2020
Q1
$526K Buy
1,855
+675
+57% +$213K 0.11% 127
2019
Q4
$384K Buy
1,180
+308
+35% +$93.4K 0.1% 179
2019
Q3
$254K Buy
872
+116
+15% +$33.2K 0.08% 181
2019
Q2
$222K Buy
756
+745
+6,773% +$205K 0.08% 175
2019
Q1
$3K Hold
11
﹤0.01% 534
2018
Q4
$2K Buy
11
+2
+22% +$469 ﹤0.01% 537
2018
Q3
$2K Hold
9
﹤0.01% 535
2018
Q2
$2K Buy
+9
New +$1.91K ﹤0.01% 536

Other funds holding TMO

CSat Investment Advisory's TMO Position: Q1 2021 in Review

CSat Investment Advisory held its Thermo Fisher Scientific (TMO) position steady in Q1 2021 at 7 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

CSat Investment Advisory first reported a position in TMO in Q2 2018 and has held it in 12 quarters since. The position peaked at $963K in Q3 2020. 2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • CSat Investment Advisory held 7 shares of Thermo Fisher Scientific worth $3K as of Q1 2021.
  • CSat Investment Advisory left its Thermo Fisher Scientific share count unchanged in Q1 2021.
  • Thermo Fisher Scientific made up ﹤0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #511 holding.
  • CSat Investment Advisory first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Thermo Fisher Scientific position peaked at $963K in Q3 2020.
  • 2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.